Welcome to our dedicated page for Smith & Nephew SEC filings (Ticker: SNN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reconstructing R&D outlays for a new robotics-assisted knee system or isolating legal reserves tied to global product recalls can make Smith & Nephew’s disclosures feel more like surgical manuals than investor reports. If you have ever Googled “Smith & Nephew insider trading Form 4 transactions” and ended up lost in exhibits, you know the problem. Stock Titan’s AI solves it by extracting plain-English takeaways from every filing the moment it hits EDGAR.
Whether you need a single metric or a full narrative, our platform links each document to the question you’re really asking—no 300-page download required:
- Quarterly pulse: The latest Smith & Nephew quarterly earnings report 10-Q filing arrives with side-by-side charts and AI commentary.
- Insider moves: Get Smith & Nephew Form 4 insider transactions real-time, plus alerts on Smith & Nephew executive stock transactions Form 4 before the market notices.
- Deep dives: Read a Smith & Nephew annual report 10-K simplified into key risks, R&D milestones, and segment revenue comparisons.
- Governance checks: The Smith & Nephew proxy statement executive compensation is distilled to pay-for-performance ratios, while every Smith & Nephew 8-K material events explained section highlights recalls, acquisitions, or leadership changes.
Our AI-powered summaries let you move from understanding Smith & Nephew SEC documents with AI to acting on them—whether you’re running discounted cash-flow models, gauging competitive threats, or seeking Smith & Nephew earnings report filing analysis before an earnings call. With real-time updates, comprehensive coverage, and jargon-free explanations, this page makes Smith & Nephew SEC filings explained simply—and quickly—so you can focus on investment decisions, not document hunts.
Smith & Nephew reported the partial vesting of conditional share awards granted under the Global Share Plan 2020. One tranche vested on 12 August 2025 from awards originally granted on 11 August 2023, which follow a three-year vesting schedule where one third vests each year.
For the disclosed individual, Rohit Kashyap (President, Advanced Wound Management and Global), 23,201 ordinary shares vested at a reported price of £13.571365. Of these, 5,670 shares were sold to cover taxation and 17,531 were retained. The transactions were executed on the London Stock Exchange for ISIN GB0009223206.
Smith & Nephew plc (SNN) has filed a Form 6-K dated 7 Aug 2025 disclosing an insider transaction under the UK Market Abuse Regulation.
- Executive: Elga Lohler, Chief HR Officer (classified as a PDMR).
- Action: Sale of ordinary shares.
- Volume: 12,559.65422 shares.
- Price: £13.407957 per share.
- Gross proceeds: ≈ £168 k.
- Venue: London Stock Exchange (XLON).
- ISIN: GB0009223206.
No financial results, guidance changes or strategic announcements accompany the filing. The disclosure appears administrative, fulfilling regulatory obligations, but investors may monitor future insider activity for sentiment cues.
On 11 July 2025, Smith & Nephew plc filed a Form 6-K reporting insider share purchases carried out on 9 July 2025 under the Company’s Employee Stock Purchase Plan (ESPP). Chief Executive Officer Deepak Nath and four other persons discharging managerial responsibilities (PDMRs) bought American Depositary Shares (ADSs) on the New York Stock Exchange at a uniform price of US$29.77358 per ADS.
Individual purchases were: Nath and Paul Connolly, each 512.29508 ADSs; Craig Gaffin, 381.29219 ADSs; Scott Schaffner, 298.19045 ADSs; and Mizanu Kebede, 114.62247 ADSs. The combined volume equals roughly 1,819 ADSs, an aggregate consideration of about US$54,000. The disclosure was made in accordance with the UK Market Abuse Regulation; no additional financial metrics, guidance or strategic updates accompanied the filing.
While routine and modest in value, the insider buying may be interpreted as a limited vote of confidence by senior management. However, because the transactions occurred through a scheduled ESPP and represent a small fraction of daily trading volume, their market impact is expected to be minimal.
FAQ
What is the current stock price of Smith & Nephew (SNN)?
What is the market cap of Smith & Nephew (SNN)?
